Literature DB >> 3731529

Leishmania mexicana amazonensis infections in 'resistant' inbred mice following removal of the draining lymph node.

S G Reed, Z A Andrade, S B Roters, J A Inverso, M Sadigursky.   

Abstract

Highly resistant (C57BL/10) and intermediately resistant (DBA/2) mice were infected subcutaneously with Leishmania mexicana amazonensis in a hind footpad subsequent to removal of the draining popliteal node. These mice developed greatly exacerbated Leishmania infections as compared to sham-operated controls or to mice infected in the contralateral footpad. The majority of mice in which the draining lymph nodes were removed prior to infection developed metastases, lost their delayed hypersensitivity responses to Leishmania, and some died. Significantly fewer metastases and no deaths were observed in the control groups. The results emphasize the importance of lymphatic control of Leishmania m. amazonensis infection in relatively resistant mouse strains.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3731529      PMCID: PMC1542168     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  Model for disseminated cutaneous leishmaniasis.

Authors:  D M Kadivar; E J Soulsby
Journal:  Science       Date:  1975-12-19       Impact factor: 47.728

2.  Variations in the response of five strains of mice to Leishmania mexicana.

Authors:  H Pérez; F Labrador; J W Torrealba
Journal:  Int J Parasitol       Date:  1979-02       Impact factor: 3.981

3.  Immunity in cutaneous leishmaniasis of the guinea-pig.

Authors:  A D Bryceson; R S Bray; R A Wolstencroft; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1970-09       Impact factor: 4.330

4.  Experimental cutaneous leishmaniasis: disseminated leishmaniasis in genetically susceptible and resistant mice.

Authors:  P A Scott; J P Farrell
Journal:  Am J Trop Med Hyg       Date:  1982-03       Impact factor: 2.345

5.  Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity.

Authors:  H W Murray; H Masur; J S Keithly
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

6.  Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.

Authors:  H W Murray; B Y Rubin; C D Rothermel
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

7.  Immunopathology of experimental cutaneous leishmaniasis.

Authors:  Z A Andrade; S G Reed; S B Roters; M Sadigursky
Journal:  Am J Pathol       Date:  1984-01       Impact factor: 4.307

8.  Mechanisms of immunity to leishmaniasis. IV. Significance of lymphatic drainage from the site of infection.

Authors:  L W Poulter; C R Pandolph
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

9.  Studies on the mechanisms of macrophage activation. II. Parasite destruction in macrophages activated by supernates from concanavalin A-stimulated lymphocytes.

Authors:  Y Buchmüller; J Mauel
Journal:  J Exp Med       Date:  1979-08-01       Impact factor: 14.307

10.  Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica.

Authors:  J G Howard; C Hale; F Y Liew
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307

  10 in total
  6 in total

1.  Age modifies the immunologic response and clinical presentation of American tegumentary leishmaniasis.

Authors:  Augusto M Carvalho; Camila F Amorim; Juliana L S Barbosa; Alexsandro S Lago; Edgar M Carvalho
Journal:  Am J Trop Med Hyg       Date:  2015-04-27       Impact factor: 2.345

2.  The Elderly Respond to Antimony Therapy for Cutaneous Leishmaniasis Similarly to Young Patients but Have Severe Adverse Reactions.

Authors:  Alexsandro Souza do Lago; Maurício Nascimento; Augusto M Carvalho; Neuza Lago; Juliana Silva; José Roberto Queiroz; Lucas P Carvalho; Albert Schriefer; Mary Wilson; Paulo Machado; Edgar M Carvalho
Journal:  Am J Trop Med Hyg       Date:  2018-03-22       Impact factor: 2.345

3.  Comparative analysis of the nitric oxide production by Leishmania sp.

Authors:  Marcelo Genestra; Wilson Jacinto Silva de Souza; Léa Cysne-Finkelstein; Leonor L Leon
Journal:  Med Microbiol Immunol       Date:  2003-06-21       Impact factor: 3.402

4.  Distinct transcriptional signatures of bone marrow-derived C57BL/6 and DBA/2 dendritic leucocytes hosting live Leishmania amazonensis amastigotes.

Authors:  Emilie Giraud; Hervé Lecoeur; Guillaume Soubigou; Jean-Yves Coppée; Geneviève Milon; Eric Prina; Thierry Lang
Journal:  PLoS Negl Trop Dis       Date:  2012-12-13

5.  Osteopontin in the host response to Leishmania amazonensis.

Authors:  Emilie Giraud; Eline Rouault; Laurence Fiette; Jean-Hervé Colle; Despoina Smirlis; Evie Melanitou
Journal:  BMC Microbiol       Date:  2019-02-08       Impact factor: 3.605

6.  Reprogramming neutral lipid metabolism in mouse dendritic leucocytes hosting live Leishmania amazonensis amastigotes.

Authors:  Hervé Lecoeur; Emilie Giraud; Marie-Christine Prévost; Geneviève Milon; Thierry Lang
Journal:  PLoS Negl Trop Dis       Date:  2013-06-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.